The temporal relationship between ABCB1 promoter hypomethylation, ABCB1 expression and acquisition of drug resistance.
about
Epigenetics of Aging and Alzheimer's Disease: Implications for Pharmacogenomics and Drug ResponseGenetic and epigenetic changes in host ABCB1 influences malaria susceptibility to Plasmodium falciparum.Interindividual epigenetic variation in ABCB1 promoter and its relationship with ABCB1 expression and function in healthy Chinese subjectsNuclear Receptors in Drug Metabolism, Drug Response and Drug Interactions.P-glycoproteins and other multidrug resistance transporters in the pharmacology of anthelmintics: Prospects for reversing transport-dependent anthelmintic resistance.Decitabine impact on the endocytosis regulator RhoA, the folate carriers RFC1 and FOLR1, and the glucose transporter GLUT4 in human tumors.Multidrug-resistant breast cancer: current perspectives.Promoter methylation patterns of ABCB1, ABCC1 and ABCG2 in human cancer cell lines, multidrug-resistant cell models and tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients.Epigenetic regulation of drug transporter expression in human tissues.Sphingolipid abnormalities in cancer multidrug resistance: Chicken or egg?Synthetic lethal hubs associated with vincristine resistant neuroblastoma.ABCB1 polymorphisms correlate with susceptibility to adult acute leukemia and response to high-dose methotrexate.Combined Influence of Genetic Polymorphism and DNA Methylation on ABCB1 Expression and Function in Healthy Chinese Males.Substituents at the C3' and C3'N positions are critical for taxanes to overcome acquired resistance of cancer cells to paclitaxel.Targeting multidrug-resistant ovarian cancer through estrogen receptor α dependent ATP depletion caused by hyperactivation of the unfolded protein response.
P2860
Q26772028-D2BC6803-523F-4653-8A68-BBC4078EA927Q33579831-45F85857-DF9E-4A7D-A310-4508AAA2AD26Q36243658-4D0DDF94-20CC-4FC2-8C73-860FB99DC70DQ37130938-B08BC636-A7F0-43A3-AE47-02A60B140894Q37390601-F69F9E20-F4C8-4228-A383-A55F7AA37D5CQ37493954-9D6ABBD7-2FD6-42BE-99CD-3E92F5FFAC9EQ37593383-B317BFF7-DE3A-4740-9593-3356571B0587Q37687390-2815744D-2B11-4BE9-A0C1-9B8EA2D7FFFBQ38942246-FE9B2285-F7AA-4F1B-8237-FB496796EB30Q39421907-385FC88E-5B88-477C-94E2-0EEB11221CA5Q39638600-14EF2A42-68D3-4457-A106-3780B367219AQ41276978-6192C34A-7249-4B7D-B54A-4003D565ADB2Q51790505-018DFA09-AAFC-4620-98B3-DEFDED8DDF5BQ52602328-62132A45-0916-4A16-A83C-759E134A099CQ53776619-BAFD0E1F-C3E9-4EAF-860B-AA4C1C40BDA2
P2860
The temporal relationship between ABCB1 promoter hypomethylation, ABCB1 expression and acquisition of drug resistance.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
The temporal relationship betw ...... cquisition of drug resistance.
@en
The temporal relationship betw ...... cquisition of drug resistance.
@nl
type
label
The temporal relationship betw ...... cquisition of drug resistance.
@en
The temporal relationship betw ...... cquisition of drug resistance.
@nl
prefLabel
The temporal relationship betw ...... cquisition of drug resistance.
@en
The temporal relationship betw ...... cquisition of drug resistance.
@nl
P2093
P2860
P356
P1476
The temporal relationship betw ...... acquisition of drug resistance
@en
P2093
A M Parissenti
S L Hembruff
P2860
P2888
P304
P356
10.1038/TPJ.2010.1
P577
2010-02-02T00:00:00Z